Sign in with Google
bullish
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
408 Views13 Jul 2017 03:26
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 9-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions28 Sep 2017
- Celltrion Has Potential Manufacturing Headaches07 Sep 2017
- More Discussions on Impacts of Celltrion's KOSPI200 Inclusion22 Aug 2017
- Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics13 Jul 2017
- Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate12 Jul 2017
- Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind03 Jul 2017
x